Indeed, the levels of IL-1β, MIP1β, and IL-6 pro-inflammatory cytokines are lower in mice vaccinated with CAF01+H56 in presence of RA treatment as compared to mice immunized with the subunit vaccine in the absence of RA, suggesting that RA treatment limits the damage caused by an excessive immune response to the infection. Here, IL1B is linked to infection.